Politics By Nicholas Florko Burr, in line to lead Senate Republicans’ health strategy, has a long history of antagonizing the FDA
Politics By Nicholas Florko and Lev Facher Trump’s making last-minute drug pricing reforms — and surprisingly, Democrats want Biden to keep the biggest one
Politics By Lev Facher Biden adviser says scientists, not political appointees, should lead public communications on Covid-19
Pharmalot By Ed Silverman House passes a bill to close a loophole in a law that gives drug makers ‘unfair’ monopolies
Politics By Lev Facher With Murthy, Nunez-Smith, and Kessler, Biden leans on experience to steer Covid-19 task force
Politics By Lev Facher ‘It’s going to be very, very scary’: Before Biden takes office, a precarious 10 weeks for escalating Covid-19 crisis
Politics By Kate Sheridan ‘I don’t think it goes away’: Pharma experts weigh in on the next 4 years of drug pricing reform
Politics By Nicholas Florko ‘Science was on the ballot’: How can public health recover from a rebuke at the polls?
Politics By Andrew Joseph, Lev Facher, Kate Sheridan, and Nicholas Florko Shalala loses — and other 2020 election results that will have big implications for health and science
Politics By Casey Ross, Usha Lee McFarling, Nicholas St. Fleur, and Becky Lang Ubiquitous hand sanitizers and grousing about masks: Snapshots from around the nation of voting in a pandemic
Politics By Lev Facher, Nicholas Florko, Andrew Joseph, and Kate Sheridan Doctors in Congress, new e-cigarette taxes, stem cells, and abortion rights: Here’s what STAT is watching tonight
A STAT Investigation By Kathleen McLaughlin HHS relaxed oversight of problematic Covid-19 tests despite being told of accuracy concerns
Politics By Lev Facher Will Fauci have a job? Will the public regain trust in the FDA? 8 of the scientific institutions and traditions on the line on Tuesday
Politics By Nicholas Florko and Kate Sheridan Biden’s policies could spell trouble for biotech — but industry CEOs are backing him anyway
Politics By Lev Facher Trump administration finalizes rule forcing insurers to disclose negotiated prices, including for drugs
Health By Andrew Joseph Is it safe to lick the ballot envelope? Public health officials take on the new challenge of making voting safe amid a pandemic
Politics By Lev Facher In a pivotal race in North Carolina, Democrats try to paint the incumbent as ‘pharma’s favorite senator’
Politics By Nicholas Florko Amid Covid-19, tiny biotech companies are hiring lobbyists for the first time
Politics By Nicholas Florko Quinn Nystrom is betting a platform laser-focused on high insulin prices will propel her to Congress
Politics By Usha Lee McFarling With wildfires burning and Covid-19 spreading, can California afford stem cell research? Voters are set to decide
Don't Miss By STAT staff As STAT turns 5, a look back at science and medicine’s biggest headlines and controversies
Politics By Lev Facher As Trump misleadingly boasts of ‘rounding the turn’ on Covid-19, Biden warns of ‘dark winter’